| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.46 | 0.008 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.01 |